- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2014
- Public Summary Document (PSD) November 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2014 PBAC Meeting - Word
Ponatinib – November 2014
Ponatinib; tablets; 15 mg and 45 mg; Iclusig®
Last updated
20 March 2015